Molecular Medical Parasitology

Erscheinungsjahr 2002
ISBN: 978-0-12-473346-6
Verlag: Elsevier Science

Buch, Englisch, 488 Seiten, Format (B × H): 204 mm x 260 mm, Gewicht: 1406 g

A valuable, new source, Molecular Medical Parasitology is the only text of its kind -- one that applies broad concepts and current scientific advances from both molecular biology and biochemistry to the study of parasitic organisms. An internationally renowned team of scientists and physicians places parasites in their broad biological contexts while still emphasizing the specifics that differentiate these organisms. Not only will researchers and faculty in parasitology find this an indispensable guide, physicians will benefit from the thorough coverage molecular biology and biochemistry's current influences on treatment and management of parasitic diseases.

Zielgruppe

Academics, professionals and researchers in parasitology. All those involved with infectious disease research.

Autoren/Hrsg.

Marr, Joseph

Nilsen, Tim W

Komuniecki, Richard W

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Medizinische Parasitologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Humangenetik
• Naturwissenschaften Biowissenschaften Molekularbiologie

Inhaltsverzeichnis

Contents include:

- RNA editing and processing
- Genomics
- Post-transcriptional gene regulation
- Genetic approaches to analysis of virulence
- Protozoa and Helminth energy metabolism
- Trypanosomatid surface carbohydrates
- Plastids, mitochondria and hydrogenosomes
- Neurotransmitters
- Drug resistance in parasites
- Medical implications of molecular parasitology

Über Autor(innen)

Marr, Joseph
Dr. J. J. Marr has held positions in academic medicine and biochemistry; as Director of Divisions of Infectious Diseases; Vice Chairman, Department of Medicine; and Professor of Medicine, Biochemistry and Microbiology at Washington University, St. Louis University and the University of Colorado. Subsequently, he was Senior Vice Presidnt for Drug Discovery at Searle Pharmaceuticals, acted as a consultant to the National Institutes of Health and the World Health Organization, and now holds the position of Vice President for Research and Development/Chief Scientific Officer, Ribozyme Pharmaceuticals, Inc.